Article Text
Editorial
Will oral antithrombin agents replace warfarin?
Abstract
The new oral direct thrombin inhibitor ximelagatran is at least equivalent to warfarin for stroke prevention in patients with non-valvar atrial fibrillation, and seems to be a promising adjunct to aspirin after acute coronary syndrome
- ACS, acute coronary syndrome
- AF, atrial fibrillation
- DTI, direct thrombin inhibitor
- ESTEEM, efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage
- INR, international normalised ratio
- NSTEMI, non-ST elevated myocardial infarction
- SPORTIF, stroke prevention using an oral thrombin inhibitor in patients with atrial fibrillation
- oral antithrombin agents
- warfarin
- thrombosis
- ximelagatran
Statistics from Altmetric.com
- ACS, acute coronary syndrome
- AF, atrial fibrillation
- DTI, direct thrombin inhibitor
- ESTEEM, efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage
- INR, international normalised ratio
- NSTEMI, non-ST elevated myocardial infarction
- SPORTIF, stroke prevention using an oral thrombin inhibitor in patients with atrial fibrillation
Linked Articles
- Miscellanea
- Miscellanea
- Miscellanea